Duong, MyLinh T <br/><br/>
LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients.  [electronic resource] 

 -  PLoS genetics  2012 
 - e1002538 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1553-7404 
<br/><br/><label>Standard No.: </label>10.1371/journal.pgen.1002538  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acinar Cells--cytology<br/>Animals<br/>Benzenesulfonates--pharmacology<br/>Breast Neoplasms--genetics<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Transformation, Neoplastic--drug effects<br/>Cyclin E--genetics<br/>Cyclin-Dependent Kinase 2--antagonists & inhibitors<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Kaplan-Meier Estimate<br/>MAP Kinase Signaling System--genetics<br/>Mammary Glands, Animal--metabolism<br/>Mice<br/>Mice, Nude<br/>Neoplasm Invasiveness--genetics<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Prognosis<br/>Protein Isoforms--genetics<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Purines--pharmacology<br/>Pyridines--pharmacology<br/>Retrospective Studies<br/>Roscovitine<br/>Sirolimus--pharmacology<br/>Sorafenib<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors